Cytek Biosciences annual operating margin
2020
2021
2022
2023
2024
2025
Cytek Biosciences Operating Margin Growth & History (CTKB)
Cytek Biosciences's operating margin was −20.04% for fiscal 2025.
View full Cytek Biosciences company overviewCytek Biosciences annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −20.04% | −9.80 pp |
| 2024 | 2024-12-31 | −10.24% | +4.19 pp |
| 2023 | 2023-12-31 | −14.43% | −13.33 pp |
| 2022 | 2022-12-31 | −1.10% | −8.26 pp |
| 2021 | 2021-12-31 | 7.16% | −7.56 pp |
| 2020 | 2020-12-31 | 14.71% | — |
Cytek Biosciences quarterly operating margin
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −23.68% | −0.38 pp |
| Q1 2026 | 2026-03-31 | −41.83% | −5.71 pp |
| Q4 2025 | 2025-12-31 | −9.00% | −14.20 pp |
| Q3 2025 | 2025-09-30 | −17.58% | −9.33 pp |
| Q2 2025 | 2025-06-30 | −23.30% | −5.01 pp |
| Q1 2025 | 2025-03-31 | −36.12% | −12.19 pp |
| Q4 2024 | 2024-12-31 | 5.20% | +5.43 pp |
| Q3 2024 | 2024-09-30 | −8.25% | +5.13 pp |
| Q2 2024 | 2024-06-30 | −18.29% | +0.08 pp |
| Q1 2024 | 2024-03-31 | −23.93% | +8.86 pp |
| Q4 2023 | 2023-12-31 | −0.23% | −0.41 pp |
| Q3 2023 | 2023-09-30 | −13.38% | −16.73 pp |
| Q2 2023 | 2023-06-30 | −18.37% | −16.15 pp |
| Q1 2023 | 2023-03-31 | −32.79% | −26.07 pp |
| Q4 2022 | 2022-12-31 | 0.17% | −3.21 pp |
| Q3 2022 | 2022-09-30 | 3.36% | −5.07 pp |
| Q2 2022 | 2022-06-30 | −2.22% | −14.75 pp |
| Q1 2022 | 2022-03-31 | −6.72% | −11.39 pp |
| Q4 2021 | 2021-12-31 | 3.39% | −23.36 pp |
| Q3 2021 | 2021-09-30 | 8.43% | +9.57 pp |
| Q2 2021 | 2021-06-30 | 12.53% | — |
| Q1 2021 | 2021-03-31 | 4.66% | — |
| Q3 2020 | 2020-09-30 | 26.74% | — |
| Q2 2020 | 2020-06-30 | −1.14% | — |
Cytek Biosciences operating margin trends
Over the last five reported fiscal years, Cytek Biosciences's operating margin decreased from 14.71% to −20.04%, a change of −34.75 percentage points. The latest reported quarter, Q2 2026, shows −23.68%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cytek Biosciences filings at SEC.gov ↗